News US device industry and FDA “colluded” on legislation to weaken regulatory oversight BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6820 (Published 17 December 2015) Cite this as: BMJ 2015;351:h6820 Article Related content Metrics Responses Peer review Related articles News Controversial bill to boost US medical research funding is passed in House of Representatives Published: 14 July 2015; BMJ 351 doi:10.1136/bmj.h3831 Analysis 21st Century Cures Act and similar policy efforts: at what cost? Published: 23 November 2015; BMJ 351 doi:10.1136/bmj.h6122 Correction US device industry and FDA “colluded” on legislation to weaken regulatory oversight Published: 18 December 2015; BMJ 351 doi:10.1136/bmj.h6911 See more UK medical organisations back dedicated sex and gender research policies BMJ December 11, 2023, 383 p2912; DOI: https://doi.org/10.1136/bmj.p2912 How bibliometrics and school rankings reward unreliable science BMJ August 17, 2023, 382 p1887; DOI: https://doi.org/10.1136/bmj.p1887 Unveiling hidden inequalities in diversity and inclusion in medical research BMJ June 13, 2023, 381 p1354; DOI: https://doi.org/10.1136/bmj.p1354 Give doctors financial incentives to take part in clinical trials, review recommends BMJ May 30, 2023, 381 p1226; DOI: https://doi.org/10.1136/bmj.p1226 How pandemic publishing struck a blow to the visibility of women’s expertise BMJ April 06, 2023, 381 p788; DOI: https://doi.org/10.1136/bmj.p788